Did you hear? Kendric Cromer, a twelve-year-old with sickle cell disease, has become the first patient to receive a groundbreaking gene therapy that has potential to cure the condition. Kendric will be undergoing this treatment with the support of the incredible medical team at Children's National Hospital. This will have a profound impact for health equity and patients around the world living with sickle cell disease.
12-year-old Kendric made history last week, being the first person in the world with sickle cell disease to begin a commercially approved gene therapy that may cure the condition. This large project is overseen by Dr. David Jacobsohn, chief of the division of Blood and Marrow Transplantation. Read more about the start to Kendric's treatment journey in The New York Times.